BioMarin’s Voxzogo has been shown to increase growth rates in children with hypochondroplasia, a genetic cause of very short stature, in a phase 2 trial. Hypochondroplasia is a form of skeletal ...

A new study explores the potential of fibroblast growth factor receptor (FGFR) antagonists in restoring defective mandibular ...